SG156633A1 - Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same - Google Patents

Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same

Info

Publication number
SG156633A1
SG156633A1 SG200906789-3A SG2009067893A SG156633A1 SG 156633 A1 SG156633 A1 SG 156633A1 SG 2009067893 A SG2009067893 A SG 2009067893A SG 156633 A1 SG156633 A1 SG 156633A1
Authority
SG
Singapore
Prior art keywords
methods
same
inflammatory drug
preparing
steroidal anti
Prior art date
Application number
SG200906789-3A
Other languages
English (en)
Inventor
Lenard M Lichtenberger
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of SG156633A1 publication Critical patent/SG156633A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
SG200906789-3A 2004-10-12 2005-10-12 Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same SG156633A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61773204P 2004-10-12 2004-10-12
US68244005P 2005-05-19 2005-05-19

Publications (1)

Publication Number Publication Date
SG156633A1 true SG156633A1 (en) 2009-11-26

Family

ID=36203456

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200906789-3A SG156633A1 (en) 2004-10-12 2005-10-12 Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same

Country Status (10)

Country Link
US (1) US8802656B2 (fr)
EP (1) EP1804766A2 (fr)
JP (1) JP2008515977A (fr)
KR (1) KR20070063587A (fr)
AU (1) AU2005295874B2 (fr)
CA (1) CA2584505A1 (fr)
IL (1) IL182505A0 (fr)
MX (1) MX2007004376A (fr)
SG (1) SG156633A1 (fr)
WO (1) WO2006044377A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080051373A1 (en) * 2003-07-31 2008-02-28 The Board Of Regents Of The University Of Texas System Parenteral preparations of GI-safer phospholipid-associated anti-inflammatories and methods of preparation and use
KR20090034385A (ko) * 2006-07-19 2009-04-07 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 염증성 장질환을 치료하기 위한 5-아미노살리실산 함유 약제 및 인지질의 제제
EP2068833B1 (fr) * 2006-07-26 2013-01-09 The Board of Regents of the University of Texas System Préparations parentérale d'anti-inflammatoires associés à des phospholipides à toxicité gi réduite, et procédés de préparation de d'utilisation de celles-ci
ITMI20061883A1 (it) * 2006-09-29 2008-03-30 Monteres S R L Formulazioni orodispersibili, gastroprotettive e taste- masking contenenti almeno un principio attivo gastrolesivo
JP5963198B2 (ja) * 2012-09-26 2016-08-03 国立研究開発法人科学技術振興機構 動的ネットワークバイオマーカーの検出装置、検出方法及び検出プログラム
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
RU2717247C2 (ru) * 2017-11-01 2020-03-19 Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермская государственная фармацевтическая академия" Министерства здравоохранения Российской Федерации (ПГФА) Способ отбора противовоспалительных средств в ряду производных антраниловой кислоты с использованием расчетных констант липофильности и ионизации
WO2020094736A1 (fr) 2018-11-07 2020-05-14 Sapir Pharmaceuticals Inc. Solutions lipidiques d'ains

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60208910A (ja) * 1984-03-31 1985-10-21 Green Cross Corp:The 水難溶性薬物・リン脂質複合体の製造方法
US5763422A (en) * 1995-01-27 1998-06-09 Board Of Regents, The University Of Texas System Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
US6656498B1 (en) 1998-11-25 2003-12-02 Vanderbilt University Cationic liposomes for gene transfer
JP4958381B2 (ja) * 2000-12-19 2012-06-20 ザ・ボード・オブ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・テキサス・システム 胃腸管保護および治療活性増強のためのレシチン油およびｎｓａｉｄｓの製剤を用いる方法および組成物

Also Published As

Publication number Publication date
EP1804766A2 (fr) 2007-07-11
WO2006044377A2 (fr) 2006-04-27
MX2007004376A (es) 2007-06-19
AU2005295874B2 (en) 2011-01-27
WO2006044377A3 (fr) 2006-08-31
JP2008515977A (ja) 2008-05-15
IL182505A0 (en) 2007-09-20
AU2005295874A1 (en) 2006-04-27
KR20070063587A (ko) 2007-06-19
CA2584505A1 (fr) 2006-04-27
US8802656B2 (en) 2014-08-12
US20060078574A1 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
SG156633A1 (en) Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same
CY1116272T1 (el) Φαρμακευτικα σκευασματα που περιεχουν μεθυλναλτρεξονη
BRPI0415288A (pt) composto, composição farmacêutica, método para tratar ou prevenir doenças, e, método para preparar o composto
IL179140A (en) Mixture of antibody-drug conjugate, a cancer drug for its cancer treatment, and a method for preparing the mixture
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
MXPA05013977A (es) Metodos y composiciones para tratar enfermedades relacionadas con amiloide.
IL175158A0 (en) Tocopherol-modified therapeutic drug compounds
DK1353672T3 (da) Syntese af 4-amino-thalidomidenantiomerer
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
SE9901875D0 (sv) Novel compounds
BRPI0518949A2 (pt) composto, uso de um composto, mÉtodo para induÇço da interrupÇço do hÁbito de fumar, composiÇço farmacÊutica, e, uso de uma composiÇço farmacÊutica
MX2007006387A (es) Derivados de piridina 3-substituidos como antagonistas h3.
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
DE602005022613D1 (en) 2,3,4-substituierte cyclopentanone als therapeutische mittel
MY150497A (en) New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them
TR200100895T2 (tr) Heterosiklik ikameli propanolamin türevleri, üretimi, ilaçları,kullanımı
WO2005033113A3 (fr) Derives indoles
UA87152C2 (ru) Твердая фармацевтическая композиция, содержащая миртазапин, и способ ее получения
WO2005081972A3 (fr) Inhibiteurs de phosphatase antitumoraux a base de maleiimide
IN2014DN04587A (fr)
MX2007007024A (es) Ligandos del receptor acetilcolina nicotinica.
SG146431A1 (en) New benzo[a]pyrano[3,2-h]acridin-7-one compounds, a process for their preparation and pharmaceutical compositions containing them
ATE265999T1 (de) Neuer ltb4-antagonist, verfahren zu dessen herstellung und dessen verwendung als arzneimittel
ZA200302392B (en) Indoline compounds, a process for their preparation and pharmaceutical compositions containing them.
ITMI20040145A1 (it) L-moprololo lpiu' tartrato